Bio Pharma Dive
JANUARY 20, 2022
Frank Clyburn, a Merck veteran and head of the company's human health division, will leave next month to run IFF, following the exit of other top leaders at the drugmaker.
World of DTC Marketing
JANUARY 20, 2022
Many companies allocate an exponentially more significant percentage of their marketing budget to paid media over organic search. However, many brands are unaware of the waste inherently included in paid media. Organic search delivers results at a lower customer acquisition cost (CAC) than paid search — 87% lower cost, per research. According to Google, organic search also offers double the ROI that paid search does.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Bio Pharma Dive
JANUARY 20, 2022
The licenses will help make molnupiravir available to people in more than 100 countries, giving public health authorities a needed tool despite the drug's limited effectiveness.
BioPharma Reporter
JANUARY 20, 2022
Valneva announced yesterday that results from a lab study showed three doses of its inactivated COVID-19 vaccine candidate, VLA2001, neutralized the Omicron variant.
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
Bio Pharma Dive
JANUARY 20, 2022
The biotech's newly minted CEO said the 25% workforce reduction should help make Zymeworks more financially stable as it focuses on developing experimental cancer drugs and forging new deals.
BioPharma Reporter
JANUARY 20, 2022
A new vaccine manufacturing plant has been opened in Cape Town by South Africa president Cyril Ramaphosa this week.
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
Pharma Times
JANUARY 20, 2022
The drug received conditional marketing authorisation in the UK from the MHRA in November
Outsourcing Pharma
JANUARY 20, 2022
An expert from patient solutions firm Trialbee discusses how the social media firm's recent ban on targeted advertising might impact patient recruitment.
pharmaphorum
JANUARY 20, 2022
Companies seek efficiency and speed to market during the content creation process, review and approval cycles, and thus the collective time for content to be approved for distribution, says Ian Hale, vice president of commercial content at Veeva Systems. Gathering content metrics is key to ensuring superior performance during each step. ‘’Content metrics is the collection of content data for both the industry as a benchmark and the individual company’s content performance,’’ says Ian.
XTalks
JANUARY 20, 2022
Life science consulting can be a rewarding career and the job outlook is promising for the future. . Perhaps you have heard of life science consulting jobs but do not exactly know what type of work is involved, or the education and experience needed to become a life science consultant. Life science consultants often work closely with a company in a life science industry — the company is referred to as the consultant’s client.
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
pharmaphorum
JANUARY 20, 2022
The UK Medicines and Healthcare products Regulatory Agency (MHRA) has approved Jyseleca (filgotinib) 200mg tablets to treat ulcerative colitis (UC) in adults whose UC is moderately to severely active, with insufficient, lost response to, or who were not tolerant to either standard treatment or a biologic agent. Jyseleca, an oral preferential inhibitor of Janus Kinase 1 (JAK1) jointly developed and commercialised by Gilead Sciences and Galapagos, is already approved in Great Britain, the EU and J
Scienmag
JANUARY 20, 2022
The Tianwen-1 Mars entry capsule successfully landed on the surface of Mars in southern Utopia planitia on May 14th, 2021 at 23:18 UTC. One of the biggest challenges is that a typical blunt body such as Tianwen-1 Mars entry capsule suffers dynamic instability in supersonic regime. To investigate the unstable Mach range of flight and […].
pharmaphorum
JANUARY 20, 2022
‘Healing at a distance’ is the literal meaning of telemedicine. According to the World Health Organization, it is defined as the use of ICT to improve patient outcomes by increasing access to care and medical information, incorporating new advancements in technology and responding and adapting to the changing health needs and contexts of societies. Within this context, it goes without saying that Covid-19 has led to a big push towards digital healthcare solutions.
Scienmag
JANUARY 20, 2022
Social networks are used more often in poor neighbourhoods than in affluent neighbourhoods, while the latter tend to consume more information from traditional online media. This is one of the conclusions of a scientific study undertaken by researchers at the Universidad Carlos III de Madrid (UC3M), the IMDEA Networks Institute, and Orange Innovation which analyses […].
Advertisement
When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.
Clairnes
JANUARY 20, 2022
The post How digital patient recruitment can reduce enrollment costs in Major Depressive Disorder clinical trials appeared first on Clinical Trial Recruitment & Management Services.
Scienmag
JANUARY 20, 2022
BATON ROUGE, Louisiana – A new federally funded study will use machine learning to predict how an individual responds to a given diet, allowing physicians to offer patients personalized nutrition prescriptions to improve health and treat chronic diseases. Credit: Pennington Biomedical Research Center BATON ROUGE, Louisiana – A new federally funded study will use machine […].
Pharma Times
JANUARY 20, 2022
Antibodies generated from only two vaccine doses offer less protection against the Omicron variant
Scienmag
JANUARY 20, 2022
Osaka, Japan – Scientists from the Graduate School of Engineering Science at Osaka University used optical tweezers for the first time inside superfluid helium. With a strongly focused beam of light, they demonstrated the stable trapping of nanoparticles at ultralow temperatures. This work may help scientists better understand the conceptual boundary that separates classical and […].
Advertisement
This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.
pharmaphorum
JANUARY 20, 2022
Twenty-seven drug makers have signed onto a deal to manufacture a generic version of molnupiravir , Merck’s oral antiviral for the treatment of COVID-19. The deal will allow affordable access to the drug in 105 low- and middle-income countries (LMICs) around the world. In October, the Geneva-based Medicines Patent Pool, a United Nations-backed public health group announced a voluntary licensing agreement by which Merck would license the drug to companies that meet certain quality-assurance
Scienmag
JANUARY 20, 2022
A clinical trial funded by the National Institutes of Health has found that giving peanut oral immunotherapy to highly peanut-allergic children ages 1 to 3 years safely desensitized most of them to peanut and induced remission of peanut allergy in one-fifth. The immunotherapy consisted of a daily oral dose of peanut flour for 2.5 years. […].
pharmaphorum
JANUARY 20, 2022
The mission to treat people who suffer from allergic rhinitis has been given a boost as two pharma companies join forces. The Swiss subsidiary of Glenmark Pharmaceuticals and Lotus International have signed a licensing agreement whereby Glenmark will handle the manufacture and supply of Ryaltris and Lotus will take charge of commercialising the drug, subject to approval.
Scienmag
JANUARY 20, 2022
Production of high-energy fats by microalgae may provide a sustainable, renewable energy source that can help tackle climate change. However, microalgae engineered to produce lipids rapidly usually grow slowly themselves, making it difficult to increase overall yields. Credit: Mark van Zee/UCLA Production of high-energy fats by microalgae may provide a sustainable, renewable energy source that […].
Advertisement
As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.
Drug Patent Watch
JANUARY 20, 2022
Annual Drug Patent Expirations for VASOSTRICT Vasostrict is a drug marketed by Par Sterile Products and is included in one NDA. It is available from two suppliers. There are fourteen…. The post New patent for Par Sterile drug VASOSTRICT appeared first on DrugPatentWatch - Make Better Decisions.
Scienmag
JANUARY 20, 2022
A significant barrier to personalized nutrition is that when we learn the effects of a diet, we do not know to whom these results apply. Using artificial intelligence and machine learning, Stevens Institute of Technology AI expert Samantha Kleinberg will try to better understand the relationship between nutrition and an individual’s biological, cultural, and economic […].
Drug Patent Watch
JANUARY 20, 2022
Annual Drug Patent Expirations for EPIDIOLEX Epidiolex is a drug marketed by Gw Res Ltd and is included in one NDA. It is available from one supplier. There are twenty…. The post New patent for Gw Res drug EPIDIOLEX appeared first on DrugPatentWatch - Make Better Decisions.
Scienmag
JANUARY 20, 2022
MUSC Hollings Cancer Center researcher Sophie Paczesny, M.D., Ph.D., received a $628,188 grant from the National Cancer Institute (NCI) to use machine learning algorithms to improve graft-versus-host disease (GVHD) treatment strategies. Her studies will validate biomarker panels that may help doctors to determine each bone marrow transplant patient’s risk of developing chronic GVHD and adjust his or […].
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
Drug Patent Watch
JANUARY 20, 2022
Annual Drug Patent Expirations for OTEZLA Otezla is a drug marketed by Amgen Inc and is included in one NDA. It is available from three suppliers. There are eleven patents…. The post New patent for Amgen Inc drug OTEZLA appeared first on DrugPatentWatch - Make Better Decisions.
Scienmag
JANUARY 20, 2022
Reston, VA (January 20, 2022)—New research has confirmed the accuracy of the novel European Association of Urology (EAU) risk classification system that groups prostate cancer patients based on their risk of recurrence. Prostate-specific membrane antigen (PSMA) PET imaging of men with prostate cancer validated the EAU groupings and provided insights that could further refine risk […].
Drug Patent Watch
JANUARY 20, 2022
Annual Drug Patent Expirations for ZYCLARA Zyclara is a drug marketed by Bausch and is included in one NDA. It is available from three suppliers. There are seven patents protecting…. The post New patent for Bausch drug ZYCLARA appeared first on DrugPatentWatch - Make Better Decisions.
Scienmag
JANUARY 20, 2022
Computers play an important role in many aspects of life today. Digital computers are the most widely used, while quantum computers are well known. However, the least known computers are the so-called Stochastic Pulse Computers. Their work is based on highly parallel logical operations between trains of electrical pulses, where the pulses occur at random […].
Advertisement
The global landscape of clinical trials is rapidly changing as studies become more complex. An increasing number of sponsors are seeking enhanced flexibility in their supply chains to address a variety of clinical supply challenges, including patient demand and reducing delays. Demand-led supply and direct-to-patient distribution are next-generation solutions that are helping to meet these growing needs, allowing for more streamlined processes and patient-centric studies.
Expert insights. Personalized for you.
294 
Let's personalize your content